NATIONAL TB RESEARCH: DETERMINATION OF PROPORTION OF TUBERCULOSIS PATIENTS EXPERIENCING CATASTROPHIC COSTS DUE TO TB TREATMENT.
The National Tuberculosis and Leprosy and Buruli Ulcer Control Programme (NTBLCP) under the auspices of the Federal Ministry of Health (FMOH) in collaboration with the Association for Reproductive and Family Health (ARFH) and World Health Organization is seeking for eligible candidates to fill the under listed positions. With funding support from the Global Fund to fight HIV/AIDS, Tuberculosis and Malaria (GFATM) and USAID/Challenge TB project, the organization is embarking on a nation-wide survey to determine the proportion of Tuberculosis patients who are experiencing catastrophic costs during TB management in Nigeria.
Tuberculosis has long been associated with health inequality and most especially affecting disproportionately the lower socioeconomic class. However, with the increasing cost of health care and economic recession, it is not clear how much households spend and to what extent the financial burden affect the health seeking behaviour, and outcome of care regarding TB disease burden. To this end, the NTBLCP is set to embark on a national survey to determine the proportion of TB patients and their households who experience catastrophic cost due to Tuberculosis. This catastrophic cost refers to total costs (indirect and direct combined) exceeding a given threshold (e.g. 20%) of the household’s annual income, and also as ‘dissaving’ (such as loans taken, property or livestock sale) incurred by patients to face health costs associated with the TB disease. The objectives of the survey are (i) to document the magnitude and main drivers of patient costs in order to guide policies on cost mitigation for the purpose of reducing financial barriers to access and adherence, (ii) to determine the baseline percentage of diagnosed TB patients treated in the network of facilities under the NTBLCP and their households, who incur direct and indirect costs beyond a defined threshold of their annual income, and (iii) to assess cost effectiveness of Tuberculosis diagnosis and treatment in public and private facilities in Nigeria.
The coverage of the study was designed to be nationally representative and it is anticipated that the outcome of this study will be useful for policy decision and programme intervention, interested candidates are encouraged to apply for the following position.
Position: Data analyst
Ref #: DA/TB-CCS/FMOH-2017
Location of assignment: Abuja, FCT, Nigeria. Duration of assignment: Three months.
The data manager will be responsible for:
Submission of Applications/Closing Date
Interested candidates are encouraged to apply and submit a detailed curriculum vitae and application letter for this research opportunity. All candidates must have good understanding of the country context and demonstrate familiarity with the Global Fund supported Tuberculosis grant in Nigeria. Candidates must demonstrate competency in supporting country’s research capacity and/or data use. All applicants for these positions must include evidence of previous consultancies and honorarium rates in their submission.
Applications are due by June 19th, 2017. Applications received after this date will not be accepted. All successful candidates will be notified of the outcome by June 26th, 2017. Selected candidates will be required to submit proof of institutional or country ethics review and approval or exemption.
Head, Monitoring & Evaluation,
Association for Reproductive and Family Health,
Floor 1, Block C, Millennium Builder’s Plaza,
Plot 251, Herbert Macaulay Way,
Central Business District,
Adjacent NNPC Towers, Abuja, FCT, Nigeria
Submission must be delivered to the above address not later than 19th June, 2017. No submission will be accepted after the closing date.
E-mail submissions will not be considered, and will be rejected.